article · Yangtze Medicine
Primary neuroendocrine carcinoma of the male breast is an exceptionally rare entity, with fewer than 50 cases documented in the literature. We present a case of a 71-year-old male with a rapidly growing retro-areolar mass. The histopathological and immunohistochemical evaluation confirmed a diagnosis of primary neuroendocrine carcinoma of the breast, with positivity for chromogranin A, synaptophysin, and CD56 and a Ki-67 proliferative index of 30%. The patient underwent total mastectomy with axillary lymph node dissection followed by adjuvant tamoxifen. At 24-month follow-up, he remains disease-free. This case highlights the diagnostic challenges of male neuroendocrine breast carcinoma (NEBC) and emphasizes the critical role of histopathology and immunohistochemistry in achieving an accurate diagnosis. We provide a comprehensive review of the literature, propose a management algorithm, and suggest future research directions to address knowledge gaps in this rare malignancy. This report adheres to the SCARE 2020 criteria for surgical case reports.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4236/ym.2025.91008
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.